Indications
| Category |
Description |
| Structural support |
Bone loss, support of depressed joint surface, deformity (e.g., scaphoid) |
| Aid bone formation |
Aid fusion of a joint or in the spine |
| Non-union |
Stimulate fracture healing in atrophic non-union |
Properties of Bone Grafts
- Osteogenic: Graft contains living cells capable of differentiating into bone. Independent of the state of the graft bed (e.g., mesenchymal stem cells, bone marrow, or cancellous autograft).
- Osteoconductive: Graft provides a scaffold for the ingrowth of capillaries and cells.
- Osteoinductive: Graft provides biologic stimulus for host cells to differentiate to form bone (e.g., BMPs, TGF-beta). The graft material itself does not contain these cells.
Classification
- Autograft
- Graft harvested from and implanted in the same individual.
- Contains viable host cells.
- Best graft option.
- Volume available is limited, leading to graft site morbidity.
- Allograft
- Graft taken from another individual of the same species.
- Allograft may be fresh, frozen, freeze-dried, or demineralized.
- Cells are destroyed in the process.
- Xenograft
- Graft obtained from a different species, often bovine or porcine.
- Synthetic graft
Sources
- Cancellous bone: Best option but volume available is limited.
- Cortical bone
- Osteochondral grafts
- Bone marrow: Contains osteogenic and osteoinductive factors.
Dangers
| Graft Type |
Risks |
| Autograft |
Graft site morbidity (scar, pain, infection, fracture) |
| Allograft |
Infection transmission (2 in a million risk of Hepatitis C or HIV), increased infection risk, immune reaction, malignant cell implantation |
Graft Incorporation
- Host bone grows into and replaces the graft.
- Allograft incorporates more slowly due to being less osteogenic and causing an immune response. Allograft may also be rejected.
- Cancellous graft incorporates quicker than cortical graft due to a greater cell volume.
Cancellous Autograft Incorporation Process
- Inflammatory response
- Creeping substitution
- Graft stimulates osteoblast activity (osteoinduction).
- Osteoclastic resorption of the graft follows.
- The graft is eventually completely replaced by creeping substitution.
- X-rays at this stage appear denser, and bone is at its strongest.
- Remodeling
- Bone density reduces, as does strength over time, following Wolff's law.
- Cancellous grafts achieve early structural strength as osteoblasts lay down bone onto the graft early on.
Cortical Graft Incorporation
- Inflammatory response
- Osteoclast cutting cones: All donor bone must be removed before appositional bone formation occurs. Mechanical strength is reduced by 50% during this process.
- Osteoblasts: With vessels, migrate into cutting cone channels and lay down lamellar bone.
- There is no remodeling phase.
- Mechanical strength takes 1-2 years to recover.
- Incorporation is often incomplete.
Allograft Incorporation (Cortical or Cancellous)
- Follows a similar process but is much slower.
- Higher chance of rejection due to a pronounced immune response, which is cellular (not humoral) and mediated by host T cells.
Vascularized Graft Incorporation
- Incorporates like a healing fracture since the biological and mechanical environment is similar.
Bone Graft Substitutes
| Type |
Description |
| Calcium Phosphates |
e.g., tricalcium phosphate, Norion (injectable). Undergoes partial conversion to hydroxyapatite. Degrades slowly, providing structural support (e.g., tibial plateau). Good osteoconductivity. |
| Hydroxyapatite |
Does not incite any immune response. |
| Other |
Various types of calcium sulfate (e.g., Osteoset), ceramic, silicone, and synthetic polymers. |
Osteoinductive Agents
- TGF Beta: Induces the formation of type 2 collagen.
- BMPs (Bone Morphogenic Proteins):
- 20 types; only BMP-2 and BMP-7 approved for use in orthopedic surgery (in the USA).
- BMP-2 is the most osteogenic and primarily osteoinductive.
- OP-1 (BMP 7) proven effective in tibial non-union.
- PDGF: Platelet-derived growth factor.
- FDGF: Fibroblast-derived growth factor.
Bone Banking
Principles
- Written consent is required if the donor is living.
- For cadavers, no objection from the next of kin is required.
Screening
- Blood tests and history are used to highlight contraindications.
Exclusions: - HIV, Hepatitis, malignancy, chronic diseases (e.g., rheumatoid arthritis, autoimmune diseases), steroid treatment, Alzheimer's, CJD, MS.
Available Products from Bone Banks
| Type |
Description |
| Fresh Frozen Femoral Heads |
Available only to hospitals that collect them. |
| Cancellous Cubes |
Freeze-dried in 1cm cubed size; purely osteoconductive with no viable cells. |
| Cortical Struts |
From femoral shafts, ranging from 2-22 cm, freeze-dried or gamma-irradiated. |
| Massive Allografts |
Proximal and distal femora and tibiae available; frozen and gamma-irradiated. |
Allograft Processing Techniques
- Physical debridement.
- Ultrasonic and ethanol treatments.
- Antibiotic soaks.
- Irradiation (reduces mechanical strength).
- Demineralization.
Allograft Storage
| Type |
Details |
| Fresh |
Immunogenic, therefore not typically done. |
| Fresh Frozen (-70°C) |
Preserves BMPs, little impact on mechanical strength, reduces immunogenicity. |
| Freeze-Dried |
Safest regarding disease transmission and immune response, eliminates BMPs, reduces mechanical strength. |
Other Methods of Augmenting Bone Healing
- Distant Corticotomy: Within the same bone, it stimulates healing elsewhere in the bone.
- Electromagnetic effect: Piezoelectric currents.
- Ultrasound: Low-intensity ultrasound shown to affect gene expression, increase osteoblast activity, and stimulate blood flow.
Written/reviewed by Kishore Puthezhath
Professor of Orthopaedics and Consultant Paediatric Orthopaedic Surgeon
FRCS (Tr & Orth) revision resource
Reviewed: September 2026
Core revision references: Miller's Review of Orthopaedics; Campbell's Operative Orthopaedics; Orthobullets. Current specialty guidelines are linked within individual notes where applicable.